Global Facial Injectable Market Research Report- Forecast to 2021

Global Facial Injectable Market Research Report- Forecast to 2021

ID: MRFR/HC/0998-CRR | April, 2017 | Region: Global | 105 pages | Cooked Research Reports

Global Facial Injectable Market Information, by Types (Botulinum Toxin, Hyaluronic Acid, polymers & Particles, and Collagen) by Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments and others) - Forecast to 2021


Market Synopsis of Facial Injectable Market:


Market Scenario:


Facial Injectable or also known as dermal fillers are products which help in a trending application known as bio-engineering or facial rejuvenation. As humans age the facial skin is bound to lose subcutaneous fat naturally, the skin is lured closer to the facial working muscles hence smile lines and wrinkles over the face become more visible. The global market for facial injectable is expected to reach USD 9.04 billion by the end of the forecasted period and is expected to grow at a CAGR of 13.2%


Study Objectives of Facial Injectable Market:

  • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the facial injectable market

  • To provide insights about factors affecting the market growth

  • To analyze the Facial Injectable market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by application and its sub-segments

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global facial injectable market.


Intended Audience



  • Facial Injectable manufacturers

  • Facial Injectable Suppliers

  • Pharmaceutical companies

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


Key Findings



  • The facial Injectable global market and is expected to reach USD9.04 billion by 2021.

  • Botulinum Toxin holds the largest share of the market.

  • North America holds the largest market share of facial injectable market and is anticipated to reach USD 3.42 billion by the end of forecast period.

  • Globally, Asia-Pacific the fastest growing region and expected to grow at the CAGR of 13.6% during the forecast period.


Segments:


Global Facial Injectable market has been segmented on the basis of types which comprises of botulinum toxin, hyaluronic acid, polymers & particles, and collagen. Polymers and particles are further divided into calcium hydroxylapatite, poly-l-lactic acid, and polymethylmethacrylate. On the basis of application which consists of Facial Line Correction Treatment, Face-Lift, Lip Treatments, and others.


Regional Analysis of Facial Injectable Market:


Globally North America is the largest market for Facial Injectable. The North American market for facial injectable is expected to grow and is expected to reach at USD 3.42 billion by the end of the forecasted period. This is due to increasing approvals of facial inject-able products in emerging markets. Europe is the second-largest market for facial injectables. Whereas Asia pacific is expected to be a growing market for facial injectable and expected to grow at a rapid rate.


Key Players for Facial Injectable Market:


Some of the key players in his market are: Allergan, Galderma, Integra Lifesciences, Merz Pharma, Sanofi, SciVision Biotech Inc, Sinclair. Suneva Medical and Valeant Pharmaceuticals.


The report for Global Facial Injectable Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
TABLE OF CONTENTS

1.1 Product Overview and Scope of Facial Injectable 12

1.2 Specifications of Facial Injectable 13

1.2.1 Hyaluronic Acid 13

1.2.2 Collagen 13

1.2.3 Botulinum Toxin 13

1.2.4 Polymers and Particles 14

2.1 Primary Research: 18

2.2 Secondary Research: 18

3.1 Drivers 19

3.1.1 Growing demand for facial aesthetic treatments 19

3.1.2 Technological advancements 19

3.1.3 Effects of pollution 19

3.1.4 Increasing acceptance of soft tissue fillers 20

3.1.5 Growing demand for dermal filler techniques from Asian region 20

3.2 Restraints: 20

3.2.1 Complication during surgery 20

3.2.2 Side effects associated with facial injectable 21

3.3 Opportunity 21

3.3.1 Rising awareness about combination therapies 21

3.4 Porters Five Forces 22

3.5 Bargaining power of suppliers 23

3.6 BARGAINING POWER OF BUYERS 23

3.7 THREAT OF NEW ENTRANTS 23

3.8 Threat of Substitutes 23

3.9 Intensity of Rivalry 23

3.10 Value Chain Analysis 24

3.10.1 Inputs 24

3.10.2 Drug Development 24

3.10.3 Manufacturing process of facial injectable 24

3.10.4 Marketing and distribution 25

3.11 Supply Chain 25

4.1 Global Facial injectable market 27

4.2 North America facial injectable market 29

4.3 North America facial injectable market, by type 32

4.4 North America facial injectable market, by application 35

4.5 North America facial injectable market, by country: price ($) 36

4.5.1 Botulinum Toxin PRICE: BY COUNTRY ($) 36

4.5.2 hyaluronic acid PRICE: BY COUNTRY ($) 36

4.5.3 polymers and particles PRICE: BY COUNTRY ($) 37

4.5.4 collagen PRICE: BY COUNTRY ($) 37

4.6 North America nuber of facial injectable procedures BY COUNTRY, 2013-2021 38

4.6.1 Botulinum Toxin 38

4.6.2 Hyaluronic Acid 38

4.6.3 Polymers & Particles 38

4.6.4 Collagen 39

4.7 US facial injectable market 40

4.7.1 u.s facial injectable market by type 40

4.7.2 u.s facial injectable market by applicationU.S. Facial Injectable Market, by Application (usd million) 41

4.7.3 u.s facial injectable market bytype: price ($) 42

4.8 Canada facial injectable market 42

4.8.1 canada facial injectable market by type 42

4.8.2 canada facial injectable market by application 44

4.8.3 canada facial injectable market by type: price ($) 45

4.9 Europe facial injectable market 45

4.9.1 Europe facial injectable market, by type 45

4.9.2 Europe facial injectable market, by application 48

4.9.3 Europe facial injectable market, by type: price ($) 50

4.10 europe Facial Injectable Market, by country (USD MIllion) 50

4.10.1 russia Facial Injectable Market 50

4.10.2 germany Facial Injectable Market 51

4.10.3 france Facial Injectable Market 51

4.10.4 U.K. Facial Injectable Market 52

4.10.5 italy Facial Injectable Market 52

4.10.6 spain Facial Injectable Market 53

4.10.7 rest of europe Facial Injectable Market 53

4.11 Europe Facial injectable market types by country (Volume) 54

4.11.1 Europe Hyaluronic Acid 54

4.11.2 Europe botulinum toxin 54

4.12 Europe facial injectable market by application (USD Million) 55

4.12.1 Russia facial injectable market 55

4.12.2 germany facial injectable market 55

4.12.3 france facial injectable market 55

4.12.4 u.k. facial injectable market 56

4.12.5 italy facial injectable market 56

4.12.6 spain facial injectable market 56

4.12.7 rest of europe facial injectable market 57

4.13 asia facial injectable market 57

4.14 Asia facial injectable market, by type 60

4.14.1 Asia botulinum toxin market, by country 60

4.14.2 Asia Hyaluronic Acid market, by country 61

4.14.3 Asia Polymers & Particles market, by country 62

4.14.4 Asia collagen market, by country 63

4.15 asia facial injectable market, by application 63

4.16 Asia facial injectable market,by type: price ($) 65

4.17 asia facial injectable procedure: BY COUNTRY 66

4.17.1 South Korea Facial Injectable Market 68

4.17.2 Japan Facial Injectable Market 69

4.17.3 China Facial Injectable Market 71

4.17.4 India Facial Injectable Market 72

4.17.5 Rest of asia facial injectable Market 73

5.1 global Facial Injectable Market Competition by Manufacturers 75

5.1.1 global Facial Injectable Sales and Market Share of Key Manufacturers (2015 and 2016) 75

5.2 Global Facial Injectable market: company share analysis, 2015 (%) 76

6.1 Galderma 77

6.1.1 Company overview 78

6.1.2 product overview 78

6.1.3 financialoverview 78

6.1.4 Manufacturing Units. 79

6.2 Allergan 81

6.2.1 Company overview 81

6.2.2 Product Overview 82

6.2.4 KEY DEVELOPMENTS 83

6.3 Merz Pharma 84

6.3.1 Company overview 85

6.3.2 Product overview 85

6.3.3 financial overview 86

6.3.4 Key Devlopments 87

6.3.5 Manufacturing Units 87

6.4 Valeant Pharmaceuticals 88

6.4.1 Company overview 89

6.4.2 Product overview 89

6.4.3 financial overview 90

6.4.4 KEY DEVELOPMENTS 90

6.4.5 Manufacturing units 91

6.5 Integra Lifesciences 94

6.5.1 Company overview 94

6.5.2 Product overview 94

6.5.4 KEY DEVELOPMENTS 95

6.5.5 manufacturing Units 96

6.6 Sanofi 97

6.6.1 Company overview 97

6.6.2 Product overview 97

6.6.3 financial overview 98

6.6.4 KEY DEVELOPMENTS 98

6.7 Sinclair 99

6.7.1 Company overview 99

6.7.2 Product overview 99

6.7.3 financial overview: 100

6.7.4 KEY DEVELOPMENTS 100

6.8 Suneva Medical 101

6.8.1 company overview 101

6.8.2 Product overview 101

6.8.3 financial overview 101

6.9 SciVision Biotech Inc. 102

6.9.1 Company overview 102

6.9.2 Product overview 102

6.9.3 financial overview 102

TABLE 1 APPLICATIONS OF FACIAL INJECTABLES 10
TABLE 2 MARKET STRUCTURE FOR GLOBAL FACIAL INJECTABLE MARKET 11
TABLE 4 GLOBAL FACIAL INJECTABLES MARKET SHARE, BY REGION 2015 (%) 21
TABLE 5 GLOBAL FACIAL INJECTABLE MARKET SHARE (%) 22
TABLE 6 FACIAL INJECTABLES IMPORT EXPORT DATA 2015 22
TABLE 7 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY USD MILLION 23
TABLE 8 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY VOLUME 24
TABLE 9 NORTH AMERICA FACIAL INJECTABLE MARKET, BY TYPE 24
TABLE 10 NORTH AMERICA FACIAL INJECTABLE MARKET, BY TYPE VOLUME 25
TABLE 11 NORTH AMERICA FACIAL INJECTABLE MARKET, BY APPLICATION USD MILLION 25
TABLE 12 BOTULINUM TOXIN MARKET, BY COUNTRY USD MILLION 26
TABLE 13 HYALURONIC ACID MARKET, BY COUNTRY USD MILLION 26
TABLE 14 POLYMERS & PARTICLES MARKET, BY COUNTRY USD MILLION 27
TABLE 15 COLLAGEN MARKET, BY COUNTRY USD MILLION 27
TABLE 16 FACIAL LINE CORRECTION TREATMENT MARKET, BY COUNTRY USD MILLION 27
TABLE 17 FACE-LIFT MARKET, BY COUNTRY USD MILLION 27
TABLE 18 LIP TREATMENTS MARKET, BY COUNTRY USD MILLION 28
TABLE 19 BOTULINUM TOXIN PRICE: BY COUNTRY ($) 28
TABLE 20 HYALURONIC ACID PRICE: BY COUNTRY ($) 28
TABLE 21 POLYMERS AND PARTICLES PRICE: BY COUNTRY ($) 28
TABLE 22 COLLAGEN PRICE: BY COUNTRY ($) 29
TABLE 23 BOTULINUM TOXIN PROCEDURES 29
TABLE 24 HYALURONIC ACIDTOXIN PROCEDURES 30
TABLE 25 POLYMERS & PARTICLES PROCEDURES 30
TABLE 26 COLLAGEN (NON-SURGICAL FACE-LIFT PROCEDURES) PROCEDURES 31
TABLE 27 U.S. FACIAL INJECTABLE MARKET, BY TYPE USD MILLION 31
TABLE 28 U.S. FACIAL INJECTABLE MARKET VOLUME BY TYPE 32
TABLE 29 U.S. FACIAL INJECTABLE MARKET, BY APPLICATION USD MILLION 33
TABLE 30 U.S. FACIAL INJECTABLE MARKET PRICE ($) 34
TABLE 31 CANADA FACIAL INJECTABLE MARKET, BY TYPE USD MILLION 34
TABLE 32 CANADA FACIAL INJECTABLE MARKET VOLUME BY TYPE 35
TABLE 33 CANADA FACIAL INJECTABLE MARKET, BY APPLICATION 36
TABLE 34 CANADA FACIAL INJECTABLE MARKET PRICE ($) 36
TABLE 35 EUROPE FACIAL INJECTABLE MARKET, BY COUNTRY USD MILLION 37
TABLE 36 EUROPE FACIAL INJECTABLES MARKET, BY TYPE USD MILLION 39
TABLE 37 EUROPE FACIAL INJECTABLES MARKET, BY TYPE VOLUME 40
TABLE 38 EUROPE FACIAL INJECTABLE MARKET, BY APPLICATION 40
TABLE 39 ASIA PACIFIC FACIAL INJECTABLE MARKET, BY COUNTRY USD MILLION 42
TABLE 41 ASIA PACIFIC FACIAL INJECTABLE MARKET, BY TYPE USD MILLION 43
TABLE 42 ASIA PACIFIC FACIAL INJECTABLE MARKET, BY APPLICATION USD MILLION 44
TABLE 43 BOTULINUM TOXIN MARKET, BY COUNTRY USD MILLION 45
TABLE 44 BOTULINUM TOXIN PRICE: BY COUNTRY ($) 46
TABLE 45 HYALURONIC ACID MARKET, BY COUNTRY USD MILLION 46
TABLE 46 HYALURONIC ACID PRICE: BY COUNTRY ($) 46
TABLE 47 POLYMERS & PARTICLES MARKET, BY COUNTRY USD MILLION 47
TABLE 48 POLYMERS & PARTICLES PRICE: BY COUNTRY ($) 47
TABLE 49 COLLAGEN MARKET, BY COUNTRY USD MILLION 48
TABLE 50 PROCEDURE NUMBER BOTULINUM TOXIN 48
TABLE 51 PROCEDURE NUMBER HYALURONIC ACID 48
TABLE 52 PROCEDURE NUMBER PROCEDURE NUMBER HYALURONIC ACID 49
TABLE 53 FACIAL LINE CORRECTION TREATMENT MARKET, BY COUNTRY USD MILLION 50
TABLE 54 FACE-LIFT MARKET, BY COUNTRY USD MILLION 50
TABLE 55 LIP TREATMENTS MARKET, BY COUNTRY USD MILLION 50
TABLE 56 SOUTH KOREA FACIAL INJECTABLE MARKET, BY TYPE USD MILLION 51
TABLE 57 SOUTH KOREA FACIAL INJECTABLE MARKET, BY APPLICATION USD MILLION 51
TABLE 58 SOUTH KOREA FACIAL INJECTABLE MARKET VOLUME 51
TABLE 59 SOUTH KOREA FACIAL INJECTABLE PRICE 52
TABLE 60 JAPAN FACIAL INJECTABLE MARKET, BY TYPE USD MILLION 52
TABLE 61 JAPAN FACIAL INJECTABLE MARKET, BY APPLICATION USD MILLION 52
TABLE 62 JAPAN FACIAL INJECTABLE MARKET VOLUME 53
TABLE 63 JAPAN FACIAL INJECTABLE PRICE 53
TABLE 64 CHINA FACIAL INJECTABLE MARKET, BY TYPE USD MILLION 53
TABLE 65 CHINA FACIAL INJECTABLE MARKET, BY APPLICATION USD MILLION 54
TABLE 66 CHINA FACIAL INJECTABLE MARKET VOLUME 54
TABLE 67 CHINA FACIAL INJECTABLE PRICE 54
TABLE 68 INDIA FACIAL INJECTABLE MARKET, BY TYPE USD MILLION 55
TABLE 69 INDIA FACIAL INJECTABLE MARKET, BY APPLICATION USD MILLION 55
TABLE 70 INDIA FACIAL INJECTABLE MARKET VOLUME 55
TABLE 71 INDIA FACIAL INJECTABLE PRICE 56
TABLE 72 REST OF ASIA FACIAL INJECTABLE MARKET, BY TYPE USD MILLION 56
TABLE 73 REST OF ASIA FACIAL INJECTABLE MARKET, BY APPLICATION USD MILLION 56
TABLE 74 GLOBAL FACIAL INJECTABLES SALES OF KEY MANUFACTURERS (2015 AND 2016) 57
TABLE 75 GLOBAL FACIAL INJECTABLES SALES SHARE BY MANUFACTURERS (2015 AND 2016) 57
TABLE 76 GLOBAL FACIAL INJECTABLES REVENUE BY MANUFACTURERS (2015 AND 2016) 58
TABLE 77 GALDERMA BASIC INFORMATION LIST 60
TABLE 78 ALLERGAN BASIC INFORMATION LIST 63
TABLE 79 MERZ BASIC INFORMATION LIST 67
TABLE 80 VALEANT PHARMACEUTICALS BASIC INFORMATION LIST 71
TABLE 81 INTEGRA LIFESCIENCES BASIC INFORMATION LIST 76
TABLE 82 SANOFI BASIC INFORMATION LIST 79
TABLE 83 SINCLAIR BASIC INFORMATION LIST 81
TABLE 84 SUNEVA MEDICAL BASIC INFORMATION LIST 83
TABLE 85 SCIVISION BASIC INFORMATION LIST 84

FIGURE 1 PICTURE OF FACIAL INJECTABLES 11
FIGURE 2 RESEARCH PROCESS 12
FIGURE 3 PORTERS FIVE FORCES MODEL 17
FIGURE 4 NORTH AMERICA FACIAL INJECTABLE MARKET, BY COUNTRY USD MILLION 23
FIGURE 5 NORTH AMERICA SALES MARKET SHARE OF FACIAL INJECTABLES BY TYPES IN 2015 (%) 24
FIGURE 6 NORTH AMERICA FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 26
FIGURE 7 US SALES MARKET SHARE OF FACIAL INJECTABLES BY TYPES IN 2015 (%) 32
FIGURE 8 US FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 33
FIGURE 9 CANADA SALES MARKET SHARE OF FACIAL INJECTABLES BY TYPES IN 2015 (%) 35
FIGURE 10 CANADA FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 36
FIGURE 11 EUROPE FACIAL INJECTABLE MARKET SHARE, BY COUNTRY USD MILLION (2015) 37
FIGURE 12 REVENUE OF FACIAL INJECTABLES BY REGIONS (2013-2021) 38
FIGURE 13 EUROPE FACIAL INJECTABLES REVENUE GROWTH RATE BY REGIONS (2015 & 2021) 38
FIGURE 14 EUROPE FACIAL INJECTABLES MARKET SHARE, BY TYPE 2015 (%) 39
FIGURE 15 EUROPE FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 40
FIGURE 16 EUROPE FACIAL INJECTABLES SALES GROWTH RATE BY APPLICATION (2013-2021) 41
FIGURE 17 EUROPE FACIAL INJECTABLES, PRICE 41
FIGURE 18 ASIA PACIFIC FACIAL INJECTABLE MARKET SHARE, BY COUNTRY 2015 (%) 42
FIGURE 19 ASIA PACIFIC FACIAL INJECTABLE MARKET SHARE, BY TYPE 2015 (%) 44
FIGURE 20 ASIA PACIFIC FACIAL INJECTABLE MARKET SHARE, BY APPLICATION 2015 (%) 45
FIGURE 21 2015 FACIAL INJECTABLES SALES SHARE BY MANUFACTURERS, 2015 (%) 58
FIGURE 22 PRODUCT PICTURE 59
FIGURE 23 PRODUCT PICTURE 66
FIGURE 24 PRODUCT PICTURE 70